Trial Designs for Evaluating Migraine Treatment

Summary

The study aims to test interactions between drug and placebo-responses in acute migraine treatment and to assess variation in adverse events according to treatment information provided. Using a clinical within-subjects, advanced balanced placebo design, patients with episodic migraine will receive six treatment conditions in a randomized order.

Timeline

Start

2024-11-13

Primary completion

2028-09

Completion

2028-09

Drugs

Indications